Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment. - Neiens V; Hansbauer EM; Jaquin TJ; Peper-Gabriel JK; Mahavadi P; Snyder ME; Grill MJ; Wurzenberger C; Konitsiotis A; Estrada-Bernal A; Heinig K; Fysikopoulos A; et al. (Nature communications, 2025)